ARCHIVES

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

This article is from The Cancer Letter archive.

Vol. 12 No. 22 | May 30, 1986

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

New Edition Of Book On Cancer Rates, Risks, Available

February 28, 1997

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

NCI Health Disparities Center Describes “Think Tank” Projects For Policy Change.

April 27, 2001

NIH Policy On Diversity In Sponsored Meetings

June 16, 1995

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014